{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:25:40Z","timestamp":1789097140772,"version":"build-2803163510"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Foxp3+ regulatory T cells (Foxp3+ Treg) play a role in regulating various types of tumors, but uncertainty still exists regarding the exact mechanism underlying Foxp3+ Treg activation in gastrointestinal malignancies. As of now, research has shown that Foxp3+ Treg expression, altered glucose metabolism, or a hypoxic tumor microenvironment all affect Foxp3+ Treg function in the bodies of tumor patients. Furthermore, it has been demonstrated that post-translational modifications are essential for mature Foxp3 to function properly. Additionally, a considerable number of non-coding RNAs (ncRNAs) have been implicated in the activation of the Foxp3 signaling pathway. These mechanisms regulating Foxp3 may one day serve as potential therapeutic targets for gastrointestinal malignancies. This review primarily focuses on the properties and capabilities of Foxp3 and Foxp3+Treg. It emphasizes the advancement of research on the regulatory mechanisms of Foxp3 in different malignant tumors of the digestive system, providing new insights for the exploration of anticancer treatments.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1404974","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T08:33:57Z","timestamp":1718181237000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Advances in Foxp3+ regulatory T cells (Foxp3+ Treg) and key factors in digestive malignancies"],"prefix":"10.3389","volume":"15","author":[{"given":"Wanyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyuan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.12151\/JMCM.2022.02-05","article-title":"Interpretation of the 2022 US cancer statistics report and comparison of cancer epidemic in China and the Q21 United State","volume":"8","author":"Zhouyi","year":"2022","journal-title":"J Multidiscip Cancer Management"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.053","article-title":"Intraepithelial effector (CD3+)\/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma","volume":"137","author":"Sinicrope","year":"2009","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.458","article-title":"Cancer-FOXP3 directly activated CCL5 to recruit FOXP3(+)Treg cells in pancreatic ductal adenocarcinoma","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00432\u2013010-0816\u20139","article-title":"Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+\/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer","volume":"136","author":"Shen","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000438631","article-title":"Hepatocellular carcinoma cells induce regulatory T cells and lead to poor prognosis via production of transforming growth factor-\u03b21","volume":"38","author":"Wang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.10.005","article-title":"Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner","volume":"134","author":"Yuan","year":"2010","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02486","article-title":"Foxp3 post-translational modifications and Treg suppressive activity","volume":"10","author":"Deng","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwab001","article-title":"Negative regulation of FOXP3 expression by c-Rel O-GlcNAcylation","volume":"31","author":"de Jesus","year":"2021","journal-title":"Glycobiology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3269","article-title":"Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants","volume":"16","author":"De Rosa","year":"2015","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800613","article-title":"SAMHD1 posttranscriptionally controls the expression of Foxp3 and Helios in human T regulatory cells","volume":"201","author":"Kim","year":"2018","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190550","article-title":"TGF-\u03b2 signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity","volume":"216","author":"Sun","year":"2019","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1700946114","article-title":"Flicr, a long noncoding RNA, modulates Foxp3 expression and autoimmunity","volume":"114","author":"Zemmour","year":"2017","journal-title":"Proc Natl Acad Sci U States A"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800928105","article-title":"T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR","volume":"105","author":"Sauer","year":"2008","journal-title":"Proc Natl Acad Sci U States A"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.06.015","article-title":"MicroRNA-125b interacts with Foxp3 to induce autophagy in thyroid cancer","volume":"26","author":"Wang","year":"2018","journal-title":"Mol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700196","article-title":"A cellular microRNA facilitates regulatory T lymphocyte development by targeting the FOXP3 promoter TATA-box motif","volume":"200","author":"Zhang","year":"2018","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2018.09.011","article-title":"Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells","volume":"97","author":"Kagoya","year":"2019","journal-title":"J autoimmunity"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1074\/jbc.A115.661611","article-title":"Poly(ADP-ribosyl)ation of FOXP3 protein mediated by PARP-1 regulates the function of regulatory T cells","volume":"291","author":"Luo","year":"2016","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189744","article-title":"Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13287\u2013018-0991\u20131","article-title":"Induction of CD4(+)CD25(+)FOXP3(+) regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation","volume":"9","author":"Khosravi","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077099","article-title":"Phosphorylation of FOXP3 by LCK downregulates MMP9 expression and represses cell invasion","volume":"8","author":"Nakahira","year":"2013","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009\u201302-207118","article-title":"Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization","volume":"115","author":"van Loosdregt","year":"2010","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aai9297","article-title":"Suppression by human FOXP3(+) regulatory T cells requires FOXP3-TIP60 interactions","volume":"2","author":"Bin Dhuban","year":"2017","journal-title":"Sci Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100903","article-title":"Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells","volume":"188","author":"Kwon","year":"2012","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3277","article-title":"Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF\u2212\u03baB\/HIF\u22121\u03b1 pathway in lung cancer","volume":"41","author":"Li","year":"2018","journal-title":"Int J Mol Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1002\/cam4.5194","article-title":"Investigation on the regulatory T cells signature and relevant Foxp3\/STAT3 axis in esophageal cancer","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00428\u2013019-02579\u20139","article-title":"IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas","volume":"475","author":"Cui","year":"2019","journal-title":"Virchows Archiv: an Int J pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2013020-0144\u20138","article-title":"PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC","volume":"5","author":"Wang","year":"2020","journal-title":"Signal transduction targeted Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.06.024","article-title":"AKT1\/FOXP3 axis-mediated expression of CerS6 promotes p53 mutant pancreatic tumorigenesis","volume":"522","author":"Qi","year":"2021","journal-title":"Cancer Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10238\u2013018-0505\u20136","article-title":"Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance","volume":"18","author":"Li","year":"2018","journal-title":"Clin Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28056","article-title":"MKL1\/miR34a\/FOXP3 axis regulates cell proliferation in gastric cancer","volume":"120","author":"Li","year":"2019","journal-title":"J Cell Biochem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29613","article-title":"miR-133a-3p\/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer","volume":"121","author":"Li","year":"2020","journal-title":"J Cell Biochem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00619","article-title":"Intratumoral FoxP3(+)Helios(+) regulatory T cells upregulating immunosuppressive molecules are expanded in human colorectal cancer","volume":"8","author":"Syed Khaja","year":"2017","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41590\u2013022-01194\u20132","article-title":"TCF-1: a maverick in T cell development and function","volume":"23","author":"Gounari","year":"2022","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.12.001","article-title":"Hepatocarcinoma cell-derived hepatoma-derived growth factor (HDGF) induces regulatory T cells","volume":"72","author":"Sun","year":"2015","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.5.3133","article-title":"Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor","volume":"177","author":"Lopes","year":"2006","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008109","article-title":"Domain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3","volume":"4","author":"Koh","year":"2009","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1542\/peds.2007\u20131863","article-title":"Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome","volume":"121","author":"Zhan","year":"2008","journal-title":"Pediatrics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.12.014","article-title":"Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome","volume":"4","author":"De Benedetti","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3577","article-title":"Foxp3 and Toll-like receptor signaling balance T(reg) cell anabolic metabolism for suppression","volume":"17","author":"Gerriets","year":"2016","journal-title":"Nat Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89160","article-title":"Foxp3 drives oxidative phosphorylation and protection from lipotoxicity","volume":"2","author":"Howie","year":"2017","journal-title":"JCI Insight"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.8606","article-title":"The effect of foxp3-overexpressing Treg cells on non-small cell lung cancer cells","volume":"17","author":"Peng","year":"2018","journal-title":"Mol Med Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3892\/mmr.2021.12097","article-title":"FOXP3\u2212induced LINC00885 promotes the proliferation and invasion of cervical cancer cells","volume":"23","author":"Liu","year":"2021","journal-title":"Mol Med Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4607","article-title":"B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance","volume":"35","author":"Huang","year":"2016","journal-title":"Oncol Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12943\u2013017-0700\u20131","article-title":"FOXP3 promotes tumor growth and metastasis by activating Wnt\/\u03b2-catenin signaling pathway and EMT in non-small cell lung cancer","volume":"16","author":"Yang","year":"2017","journal-title":"Mol cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s12885\u2013016-2419\u20136","article-title":"Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma","volume":"16","author":"Song","year":"2016","journal-title":"BMC cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419\u2013018-0790\u20138","article-title":"FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death disease"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29482","article-title":"FOXP3 suppresses breast cancer metastasis through downregulation of CD44","volume":"137","author":"Zhang","year":"2015","journal-title":"Int J cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41419\u2013018-0448\u20136","article-title":"Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer","volume":"9","author":"Gao","year":"2018","journal-title":"Cell Death disease"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.193","article-title":"Foxp3 is a key downstream regulator of p53-mediated cellular senescence","volume":"36","author":"Kim","year":"2017","journal-title":"Oncogene"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201907_18426","article-title":"MicroRNA-155 and FOXP3 jointly inhibit the migration and invasion of colorectal cancer cells by regulating ZEB2 expression","volume":"23","author":"Yang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.07.021","article-title":"Strong TCR stimulation promotes the stabilization of Foxp3 expression in regulatory T cells induced in vitro through increasing the demethylation of Foxp3 CNS2","volume":"503","author":"Wakamatsu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3390\/ijms19072036","article-title":"FOXP3 activates SUMO-conjugating UBC9 gene in MCF7 breast cancer cells","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1007-4287.2019.05.003","article-title":"Hypoxia inducible factor-1 \u03b1 The expression and clinical significance of Foxp3 in colorectal cancer tissue Chinese Experimental Diagnosis","volume":"23","author":"Yanli","year":"2019","journal-title":"Chin J Anal Lab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202366109","article-title":"Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa","volume":"109","author":"Clambey","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1080\/10715762.2020.1745202","article-title":"Redox regulation of regulatory T-cell differentiation and functions","volume":"54","author":"Patwardhan","year":"2020","journal-title":"Free Radical Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.MR1217-481R","article-title":"Hypoxia-inducible factor 1\u03b1 plays a predominantly negative role in regulatory T cell functions","volume":"104","author":"Hsu","year":"2018","journal-title":"J leukocyte Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12967\u2013021-02907\u20131","article-title":"Long non-coding RNA MEG3 mediates the miR-149\u20133p\/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer","volume":"19","author":"Xu","year":"2021","journal-title":"J Trans Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13046\u2013022-02550\u20138","article-title":"IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p\/FOXP3 axis","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B63","article-title":"Inhibition of FOXP3 expression on DCs activation and immune function in pancreatic cancer","author":"Xuejia","year":"2015","journal-title":"J Nanjing Univ"},{"key":"B64","article-title":"The effects and clinical significance of PD-1, PDL-1, and Foxp3 proteins on pancreatic ductal adenocarcinoma","author":"Ke","year":"2018","journal-title":"J Nanjing Univ"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/0008\u20135472.Can-06\u20133304","article-title":"Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer","volume":"67","author":"Hinz","year":"2007","journal-title":"Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2017.09.030","article-title":"CD25-expressing Th17 cells mediate CD8(+) T cell suppression in CTLA-4 dependent mechanisms in pancreatic ductal adenocarcinoma","volume":"360","author":"Lang","year":"2017","journal-title":"Exp Cell Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.19401\/j.cnki.1007\u20133639.2023.04.001","article-title":"New progress in research and diagnosis and treatment of gastric cancer in 2022","volume":"33","author":"Jinling","year":"2023","journal-title":"Chin J Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1159\/000479442","article-title":"The role of tumoral FOXP3 on cell proliferation, migration, and invasion in gastric cancer","volume":"42","author":"Zhang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1433520","article-title":"PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers","volume":"7","author":"Ying","year":"2018","journal-title":"Oncoimmunology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2018097","article-title":"Transcriptional activation of Proteasome 26S non-ATPase subunit 7 by forkhead box P3 participates in gastric cancer cell proliferation and apoptosis","volume":"13","author":"Xu","year":"2022","journal-title":"Bioengineered"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262\u2013021-02950\u20133","article-title":"Intratumoral Foxp3(+)ROR\u03b3t(+) T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients","volume":"71","author":"Fei","year":"2022","journal-title":"Cancer Immunol Immunother: CII"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.11.039","article-title":"TNF\u03b1 induced FOXP3-NF\u03baB interaction dampens the tumor suppressor role of FOXP3 in gastric cancer cells","volume":"430","author":"Hao","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000026951","article-title":"The antioncogenic effect of Beclin-1 and FOXP3 is associated with SKP2 expression in gastric adenocarcinoma","volume":"100","author":"Kim","year":"2021","journal-title":"Medicine"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.11.065","article-title":"FoxP3 inhibits proliferation and induces apoptosis of gastric cancer cells by activating the apoptotic signaling pathway","volume":"430","author":"Ma","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.11.030","article-title":"FOXP3 inhibits NF-\u03baB activity and hence COX2 expression in gastric cancer cells","volume":"26","author":"Hao","year":"2014","journal-title":"Cell signalling"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8277","article-title":"Label-free quantitative proteomic analysis identifies CTNNB1 as a direct target of FOXP3 in gastric cancer cells","volume":"15","author":"Pan","year":"2018","journal-title":"Oncol letters"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.13376\/j.cbls\/2019098","article-title":"Research progress on stem cell markers and signaling pathways in colon cancer life sciences","volume":"31","author":"Ziyi","year":"2019","journal-title":"China Bull Life Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1186\/1476\u20134598-13\u2013153","article-title":"Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival","volume":"13","author":"Zhuo","year":"2014","journal-title":"Mol cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"592","DOI":"10.21037\/atm-20\u20133287","article-title":"FOXP3 promotes colorectal carcinoma liver metastases by evaluating MMP9 expression via regulating S-adenosylmethionine metabolism","volume":"8","author":"Wang","year":"2020","journal-title":"Ann Trans Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01677-w","article-title":"Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancer","volume":"40","author":"Cui","year":"2021","journal-title":"Oncogene"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2022.2040050","article-title":"Investigation of possible associations between tryptophan\/kynurenine status and FOXP3 expression in colorectal cancer","volume":"82","author":"Ay","year":"2022","journal-title":"Scandinavian J Clin Lab Invest"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25902","article-title":"CD103 is a hallmark of tumor-infiltrating regulatory T cells","volume":"129","author":"Anz","year":"2011","journal-title":"Int J cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41590\u2013021-00987\u20131","article-title":"TCF-1 controls T(reg) cell functions that regulate inflammation, CD8(+) T cell cytotoxicity and severity of colon cancer","volume":"22","author":"Osman","year":"2021","journal-title":"Nat Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053630","article-title":"Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17974","article-title":"FOXP3 inhibits cancer stem cell self-renewal via transcriptional repression of COX2 in colorectal cancer cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.11735\/j.issn.1004-0242.2020.03.A005","article-title":"Analysis of the current situation and trend of liver cancer prevalence","volume":"29","author":"Qian","year":"2020","journal-title":"Chin Oncol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7150\/ijms.8352","article-title":"The expression levels of transcription factors T-bet, GATA-3, ROR\u03b3t and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance","volume":"12","author":"Lin","year":"2015","journal-title":"Int J Med Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12418","article-title":"Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma","volume":"29","author":"Huang","year":"2014","journal-title":"J Gastroenterol hepatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8642","article-title":"Matrix metalloproteinase 12 expression is associated with tumor FOXP3(+) regulatory T cell infiltration and poor prognosis in hepatocellular carcinoma","volume":"16","author":"He","year":"2018","journal-title":"Oncol letters"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i23.2938","article-title":"Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling","volume":"18","author":"Yang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15129","article-title":"The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion","volume":"8","author":"Jiang","year":"2017","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.928022","article-title":"lncRNA NEAT1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the FOXP3\/PKM2 axis","volume":"12","author":"Pan","year":"2022","journal-title":"Front Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.012518","article-title":"The FKH domain in FOXP3 mRNA frequently contains mutations in hepatocellular carcinoma that influence the subcellular localization and functions of FOXP3","volume":"295","author":"Ren","year":"2020","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154292","article-title":"FOXP3 and SQSTM1\/P62 correlate with prognosis and immune infiltration in hepatocellular carcinoma","volume":"242","author":"Liu","year":"2023","journal-title":"Pathol Res practice"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101918","article-title":"Epigenetic control of Foxp3 in intratumoral T-cells regulates growth of hepatocellular carcinoma","volume":"11","author":"Liu","year":"2019","journal-title":"Aging"},{"key":"B96","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41389-020-00283-x","article-title":"Nuclear FOXP3 inhibits tumor growth and induced apoptosis in hepatocellular carcinoma by targeting c-Myc","volume":"9","author":"Gong","year":"2020","journal-title":"Oncogenesis"},{"key":"B97","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12885\u2013017-3633\u20136","article-title":"FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-\u03b2\/Smad2\/3 signaling pathway","volume":"17","author":"Shi","year":"2017","journal-title":"BMC cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8456852","article-title":"A water-soluble hydrogen sulfide donor suppresses the growth of hepatocellular carcinoma via inhibiting the AKT\/GSK-3\u03b2\/\u03b2-catenin and TGF-\u03b2\/smad2\/3 signaling pathways","volume":"2023","author":"Duan","year":"2023","journal-title":"J Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.01.022","article-title":"Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer","volume":"117","author":"Barua","year":"2018","journal-title":"Lung Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1456612","article-title":"The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma","volume":"7","author":"Kachler","year":"2018","journal-title":"Oncoimmunology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.11817\/j.issn.1672-7347.2018.08.003","article-title":"Expression and clinicopathological significance of Foxp3 and VISTA in cervical cancer","volume":"13","author":"Li","year":"2021","journal-title":"Am J Transl Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.740588","article-title":"FOXP3\/HAT1 axis controls Treg infiltration in the tumor microenvironment by inducing CCR4 expression in breast cancer","volume":"13","author":"Sarkar","year":"2022","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22\u20133080","article-title":"The expression landscape of FOXP3 and its prognostic value in breast cancer","volume":"10","author":"Li","year":"2022","journal-title":"Ann Trans Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2014.17.1.8","article-title":"Zonal difference and prognostic significance of Foxp3 regulatory T cell infiltration in breast cancer","volume":"17","author":"Kim","year":"2014","journal-title":"J Breast Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.12.004","article-title":"Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery","volume":"18","author":"Chen","year":"2014","journal-title":"Int immunopharmacol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33804","article-title":"Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial","volume":"127","author":"Romesser","year":"2021","journal-title":"Cancer"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022\u2013003717","article-title":"Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma","volume":"32","author":"McEachron","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Nishikawa","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12368","article-title":"Clinical implications of CD4(+)CD25(+)Foxp3(+)Regulatory T cell frequencies after CHP-MAGE-A4 cancer vaccination","volume":"38","author":"Wada","year":"2018","journal-title":"Anticancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41423\u2013020-0488\u20136","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s11154\u2013021-09684\u20138","article-title":"The emerging role of transcription factor FOXP3 in thyroid cancer","volume":"23","author":"Gong","year":"2022","journal-title":"Rev endocrine Metab Disord"},{"key":"B113","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12957\u2013021-02420\u20131","article-title":"The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis","volume":"19","author":"Hu","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009\u20132564","article-title":"Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer","volume":"95","author":"French","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Institute"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apcsb.2019.11.010","article-title":"Targeting FOXP3 complex ensemble in drug discovery","volume":"121","author":"Huang","year":"2020","journal-title":"Adv Protein Chem Struct Biol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5421","article-title":"Ultrasound-targeted microbubble destruction-mediated Foxp3 knockdown may suppress the tumor growth of HCC mice by relieving immunosuppressive Tregs function","volume":"15","author":"Shi","year":"2018","journal-title":"Exp Ther Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209044119","article-title":"Inhibition of FOXP3 by stapled alpha-helical peptides dampens regulatory T cell function","volume":"119","author":"Hawley","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1172\/jci131375","article-title":"Inhibiting the coregulator CoREST impairs Foxp3+ Treg function and promotes antitumor immunity","volume":"130","author":"Xiong","year":"2020","journal-title":"J Clin Invest"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.11817\/j.issn.1672-7347.2018.08.003","article-title":"The role of methotrexate in regulating the number of regulatory T cells and Foxp3 expression in the treatment of psoriasis","volume":"43","author":"Yehong","year":"2018","journal-title":"J Cent South Univ (Medical Edition)"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/978\u2013981-15\u20133266-5_23","article-title":"Therapeutic development of immune checkpoint inhibitors","volume":"1248","author":"Wang","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2022.01.001","article-title":"Immune-related adverse events in various organs caused by immune checkpoint inhibitors","volume":"71","author":"Okiyama","year":"2022","journal-title":"Allergology Int"},{"key":"B123","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1200\/edbk_289911","article-title":"Dermatologic adverse events of systemic anticancer therapies: cytotoxic chemotherapy, targeted therapy, and immunotherapy","volume":"40","author":"Deutsch","year":"2020","journal-title":"Am Soc Clin Oncol Educ book Am Soc Clin Oncol Annu Meeting"},{"key":"B124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2016.02.010","article-title":"Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor","volume":"60","author":"Belum","year":"2016","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1097\/cco.0000000000000290","article-title":"Dermatologic complications of anti-PD-1\/PD-L1 immune checkpoint antibodies","volume":"28","author":"Sibaud","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2017.10.003","article-title":"Anti-PD1\/PDL1 induced psoriasis","volume":"41","author":"Voudouri","year":"2017","journal-title":"Curr Probl Cancer"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14830","article-title":"Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors","volume":"34","author":"Cutroneo","year":"2021","journal-title":"Dermatol Ther"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac456","article-title":"Cardiovascular complications of immune checkpoint inhibitors for cancer","volume":"43","author":"Thuny","year":"2022","journal-title":"Eur Heart J"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1255825","article-title":"Immune-related cardiovascular toxicities of PD-1\/PD-L1 inhibitors in solid tumors: an updated systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1006860","article-title":"Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2014.07.011","article-title":"Acquired and intrinsic resistance in cancer immunotherapy","volume":"8","author":"Kelderman","year":"2014","journal-title":"Mol Oncol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016646","article-title":"Mechanism and strategies of immunotherapy resistance in colorectal cancer","volume":"13","author":"Shan","year":"2022","journal-title":"Front Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12935\u2013023-02902\u20130","article-title":"Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired","volume":"23","author":"Marei","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1158\/2159\u20138290.Cd-20\u20131638","article-title":"Overcoming resistance to tumor-targeted and immune-targeted therapies","volume":"11","author":"Aldea","year":"2021","journal-title":"Cancer Discov"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/s40257\u2013018-0384\u20133","article-title":"Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails","volume":"19","author":"Lacouture","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.3390\/ijms24098188","article-title":"Pathogenesis of oral toxicities associated with targeted therapy and immunotherapy","volume":"24","author":"Villa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/s00520\u2013017-3629\u20134","article-title":"Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors","volume":"25","author":"Vigarios","year":"2017","journal-title":"Support Care Cancer"},{"key":"B138","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978\u20133-030\u201341008-7_17","article-title":"Immune-related oral, otologic, and ocular adverse events","volume":"1244","author":"Srivastava","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.07.022","article-title":"Treatment recommendations for nail unit toxicities secondary to targeted cancer therapy based on collective experience and evidence-based literature review","volume":"87","author":"Wetzel","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.02.016","article-title":"Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description","volume":"10","author":"van Damme","year":"2021","journal-title":"JAAD Case Rep"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0013-y","article-title":"Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury","volume":"31","author":"Zen","year":"2018","journal-title":"Mod Pathol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/s00432\u2013020-03448\u20138","article-title":"Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers","volume":"147","author":"Yamamoto","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.3390\/cancers13225665","article-title":"Hepatotoxicity in patients with hepatocellular carcinoma on treatment with immune checkpoint inhibitors","volume":"13","author":"Personeni","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000063","article-title":"Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known","volume":"7","author":"Zheng","year":"2023","journal-title":"Hepatol Commun"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34025","article-title":"A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability","volume":"128","author":"Bellone","year":"2022","journal-title":"Cancer"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2021.09.004","article-title":"Rheumatological adverse events of cancer therapy with immune checkpoint inhibitors","volume":"53","author":"Cano-Cruz","year":"2022","journal-title":"Arch Med Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15237","article-title":"Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors","volume":"176","author":"Zarbo","year":"2017","journal-title":"Br J Dermatol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14171","article-title":"Alopecia areata as an immune-related adverse event of immune checkpoint inhibitors: A review","volume":"33","author":"Antoury","year":"2020","journal-title":"Dermatol Ther"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.01.033","article-title":"Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors","volume":"68","author":"De Martin","year":"2018","journal-title":"J hepatol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021\u2013002435","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events","volume":"9","author":"Brahmer","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B151","doi-asserted-by":"publisher","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","article-title":"Management of immunotherapy-related toxicities, version 1.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Thompson","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0013","article-title":"Management of immunotherapy-related toxicities, version 1.2019","volume":"17","author":"Thompson","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2020.12.010","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioactive Materials"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01739","article-title":"Combining immune checkpoint inhibitors with conventional cancer therapy","volume":"9","author":"Yan","year":"2018","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2017.10.020","article-title":"Combination immunotherapy of MUC1 mRNA nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast cancer","volume":"26","author":"Liu","year":"2018","journal-title":"Mol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1404974\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T08:34:19Z","timestamp":1718181259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1404974\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":155,"alternative-id":["10.3389\/fimmu.2024.1404974"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1404974","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"article-number":"1404974"}}